NCT03549871: A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis
- State
- Completed
- Phase
- Phase 3
- People
- 80 taking part
- Started
- 25 Jul 2018
- Primary completion
- 20 Jan 2022
- Arms
- Fitusiran
- Results
- Posted on the registry
- 8 Jun 2018: Trial registered
- 25 Jul 2018: Trial started
- 25 Mar 2022: Trial completed
- 6 Feb 2023: Trial results posted